ImpactAlpha, May 25 — Singapore-based SwipeRx (formerly mClinica) has raised $27 million to build digital tools for pharmacies in Southeast Asia.
Pharmacies are the initial point of contact with the health system in the many underserved and low-income areas in Southeast Asia. SwipeRx aims to facilitate the delivery of quality and affordable medicines to hundreds of millions of patients.
SwipeRx’s Farouk Meralli said the company’s mobile app helps its network of 45,000 pharmacies “to perform all of their daily tasks from education to purchasing to inventory financing.”
Digital disruption
Meralli said the funding “reaffirms our commitment to disrupt this deeply fragmented industry.” SwipeRx will expand in Indonesia, Vietnam, Malaysia, Thailand, Cambodia and The Philippines.
The Series B round, led by early investor MDI Ventures, includes equity and debt capital from Johnson & Johnson Impact Ventures, the Gates Foundation and others (J&J Impact Ventures sponsors ImpactAlpha’s coverage of Investing in Health).
